Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) Short Interest Update

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totaling 76,340 shares, a growth of 116.4% from the June 30th total of 35,280 shares. Based on an average daily trading volume, of 93,500 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.0% of the company’s stock are sold short.

Otsuka Stock Performance

Shares of OTCMKTS:OTSKY traded up $0.43 during trading on Tuesday, reaching $34.73. The stock had a trading volume of 38,070 shares, compared to its average volume of 39,845. The stock has a fifty day simple moving average of $34.23 and a two-hundred day simple moving average of $33.38. The company has a quick ratio of 1.67, a current ratio of 2.17 and a debt-to-equity ratio of 0.05. Otsuka has a 52 week low of $23.50 and a 52 week high of $37.52. The firm has a market capitalization of $37.31 billion and a price-to-earnings ratio of 14.65.

Otsuka (OTCMKTS:OTSKY) last posted its quarterly earnings data on Tuesday, April 28th. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.16. The business had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.78 billion. Otsuka had a return on equity of 12.33% and a net margin of 15.01%. As a group, analysts anticipate that Otsuka will post 1.96 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Otsuka from a “strong sell” rating to a “hold” rating in a research report on Tuesday, March 31st. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.